Cleared Traditional

K020911 - MID LABS AUTONOMOUS VIT ENHANCER (AVE)

K020911 is an FDA 510(k) clearance for MID LABS AUTONOMOUS VIT ENHANCER (AVE), manufactured by Medical Instrument Development Laboratories, Inc.. The device is a Class 2 Ophthalmic device with product code HQE cleared through the Traditional 510(k) pathway after a 40-day FDA review.

K020911 · Medical Instrument Development Laboratories, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2002
Decision
40d
Days
Class 2
Risk

K020911 is an FDA 510(k) clearance for the MID LABS AUTONOMOUS VIT ENHANCER (AVE). Classified as Instrument, Vitreous Aspiration And Cutting, Ac-powered (product code HQE), Class II - Special Controls.

Submitted by Medical Instrument Development Laboratories, Inc. (San Leandro, US). The FDA issued a Cleared decision on April 29, 2002 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4150 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medical Instrument Development Laboratories, Inc. devices

FDA 510(k) Submission Details - K020911

510(k) Number K020911 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 20, 2002
Decision Date April 29, 2002
Days to Decision 40 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 110d · This submission: 40d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQE Device Classification - Class 2, Special Controls

Product Code HQE Instrument, Vitreous Aspiration And Cutting, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4150
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQE Instrument, Vitreous Aspiration And Cutting, Ac-powered

All 75
Devices cleared under the same product code (HQE) and FDA review panel - the closest regulatory comparables to K020911.
UniVit HE, UniVit UHS
K212763 · Visioncare Devices, LLC · Aug 2022
ULTIMATE VIT ENHAMCER (UVE)
K102222 · Medical Instrument Development Laboratories, Inc. · Apr 2011
VIT ENHANCER
K992943 · Medical Instrument Development Laboratories, Inc. · Dec 1999
PEREGRINE OPTIPORT VITRECTOMY PROBE MODEL PD500.20
K980399 · Peregrine Surgical , Ltd. · Apr 1998
PVRS-PEREGRINE VITREORETINAL SCISSOR MODEL PD505.10
K980400 · Peregrine Surgical , Ltd. · Apr 1998
STORZ MILLENNIUM MICROSURGICL SYSTEM HIGH SPEED VITRECTOMY SYSTEM
K980488 · Storz Instrument Co. · Mar 1998